Efficacy and Adverse Events of Carboplatin Desensitisation Therapy for Gynaecological Cancer: A Retrospective Study

Background: Carboplatin, the key drug used in treating gynaecological cancer, has an approximately 12–16% risk of hypersensitivity reactions. We aimed to investigate the efficacy and adverse effects of carboplatin desensitisation therapy for gynaecological cancer. Methods: The desensitisation protoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Akihito, Kamoi, Seiryu, Matsuda, Shigeru, Kawase, Rieko, Nakanishi, Kazuho, Suzuki, Shunji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032487/
https://www.ncbi.nlm.nih.gov/pubmed/35447874
http://dx.doi.org/10.3390/medicines9040026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032487/
https://www.ncbi.nlm.nih.gov/pubmed/35447874
http://dx.doi.org/10.3390/medicines9040026

Ejemplares similares